Autologous haematopoietic cell transplantation in elderly patients with multiple myeloma
Author:
Affiliation:
1. Imperial College London; London UK
2. Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation (EBMT); Hamburg Germany
3. Hôpital Saint-Antoine; Paris France
4. University Medical Centre; Hamburg Germany
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13608/fullpdf
Reference54 articles.
1. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome;Attal;New England Journal of Medicine,1996
2. Trends in autologous hematopoietic cell transplantation for multiple myeloma in Europe: increased use and improved outcomes in elderly patients in recent years;Auner;Bone Marrow Transplantation,2015
3. Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years;Badros;British Journal of Haematology,2001
4. High-dose melphalan with autologous bone marrow transplantation for multiple myeloma;Barlogie;Blood,1986
5. Feasibility of autologous hematopoietic stem cell transplant in patients aged ≥70 years with multiple myeloma;Bashir;Leukaemia & Lymphoma,2012
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Assessing Outcomes in Patients With Multiple Myeloma Postautologous Stem Cell Transplantation: Contrasting the Effects of Melphalan Dosages at 200 mg/m2 versus 140 mg/m2;Clinical Lymphoma Myeloma and Leukemia;2024-09
2. Tandem autologous stem cell transplantation in elderly patients with myeloma: A multicenter retrospective analysis;European Journal of Haematology;2023-01-17
3. Mobilization Strategies in Myeloma Patients Intended for Autologous Hematopoietic Cell Transplantation;Transfusion Medicine and Hemotherapy;2023
4. The limited use of autologous hematopoietic stem cell transplant for fit older patients with multiple myeloma in India: a retrospective analysis;Journal of the Egyptian National Cancer Institute;2022-05-16
5. Optimizing Hematopoietic Cellular Transplantation in Older Adults with Hematologic Malignancies;Advances in Oncology;2022-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3